These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26808982)

  • 1. Application of Diffusion Tensor Imaging Parameters to Detect Change in Longitudinal Studies in Cerebral Small Vessel Disease.
    Zeestraten EA; Benjamin P; Lambert C; Lawrence AJ; Williams OA; Morris RG; Barrick TR; Markus HS
    PLoS One; 2016; 11(1):e0147836. PubMed ID: 26808982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion tensor image segmentation of the cerebrum provides a single measure of cerebral small vessel disease severity related to cognitive change.
    Williams OA; Zeestraten EA; Benjamin P; Lambert C; Lawrence AJ; Mackinnon AD; Morris RG; Markus HS; Charlton RA; Barrick TR
    Neuroimage Clin; 2017; 16():330-342. PubMed ID: 28861335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies.
    Croall ID; Lohner V; Moynihan B; Khan U; Hassan A; O'Brien JT; Morris RG; Tozer DJ; Cambridge VC; Harkness K; Werring DJ; Blamire AM; Ford GA; Barrick TR; Markus HS
    Clin Sci (Lond); 2017 Jun; 131(12):1361-1373. PubMed ID: 28487471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials.
    Benjamin P; Zeestraten E; Lambert C; Ster IC; Williams OA; Lawrence AJ; Patel B; MacKinnon AD; Barrick TR; Markus HS
    J Cereb Blood Flow Metab; 2016 Jan; 36(1):228-40. PubMed ID: 26036939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter changes and gait decline in cerebral small vessel disease.
    van der Holst HM; Tuladhar AM; Zerbi V; van Uden IWM; de Laat KF; van Leijsen EMC; Ghafoorian M; Platel B; Bergkamp MI; van Norden AGW; Norris DG; van Dijk EJ; Kiliaan AJ; de Leeuw FE
    Neuroimage Clin; 2018; 17():731-738. PubMed ID: 29270357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.
    Pasi M; Poggesi A; Salvadori E; Diciotti S; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Mascalchi M; Inzitari D; Pantoni L
    Int J Geriatr Psychiatry; 2016 Jun; 31(6):611-8. PubMed ID: 26489377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study.
    van Norden AG; de Laat KF; van Dijk EJ; van Uden IW; van Oudheusden LJ; Gons RA; Norris DG; Zwiers MP; de Leeuw FE
    Biochim Biophys Acta; 2012 Mar; 1822(3):401-7. PubMed ID: 21549191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease.
    Zeestraten EA; Lawrence AJ; Lambert C; Benjamin P; Brookes RL; Mackinnon AD; Morris RG; Barrick TR; Markus HS
    Neurology; 2017 Oct; 89(18):1869-1876. PubMed ID: 28978655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease.
    Egle M; Hilal S; Tuladhar AM; Pirpamer L; Bell S; Hofer E; Duering M; Wason J; Morris RG; Dichgans M; Schmidt R; Tozer DJ; Barrick TR; Chen C; de Leeuw FE; Markus HS
    Neuroimage Clin; 2022; 35():103114. PubMed ID: 35908307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study.
    Lawrence AJ; Patel B; Morris RG; MacKinnon AD; Rich PM; Barrick TR; Markus HS
    PLoS One; 2013; 8(4):e61014. PubMed ID: 23613774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral small vessel disease: Recent advances and future directions.
    Markus HS; de Leeuw FE
    Int J Stroke; 2023 Jan; 18(1):4-14. PubMed ID: 36575578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression in small-vessel disease relates to white matter ultrastructural damage, not disability.
    Brookes RL; Herbert V; Lawrence AJ; Morris RG; Markus HS
    Neurology; 2014 Oct; 83(16):1417-23. PubMed ID: 25230999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function in small vessel disease: the additional value of diffusion tensor imaging to conventional magnetic resonance imaging: the RUN DMC study.
    van Norden AG; van Uden IW; de Laat KF; van Dijk EJ; de Leeuw FE
    J Alzheimers Dis; 2012; 32(3):667-76. PubMed ID: 22850313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With 8-Year Mortality in Older Patients With Cerebral Small Vessel Disease: The Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study.
    van der Holst HM; van Uden IW; Tuladhar AM; de Laat KF; van Norden AG; Norris DG; van Dijk EJ; Rutten-Jacobs LC; de Leeuw FE
    JAMA Neurol; 2016 Apr; 73(4):402-9. PubMed ID: 26831360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of white matter at the centrum semiovale level with magnetic resonance spectroscopy and diffusion tensor imaging in cerebral small vessel disease.
    Huang LA; Ling XY; Li C; Zhang SJ; Chi GB; Xu AD
    Genet Mol Res; 2014 Apr; 13(2):2683-90. PubMed ID: 24782057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor tractography in cerebral small vessel disease: correlation with cognitive function.
    D'Souza MM; Gorthi SP; Vadwala K; Trivedi R; Vijayakumar C; Kaur P; Khushu S
    Neuroradiol J; 2018 Feb; 31(1):83-89. PubMed ID: 29027841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms.
    Baykara E; Gesierich B; Adam R; Tuladhar AM; Biesbroek JM; Koek HL; Ropele S; Jouvent E; ; Chabriat H; Ertl-Wagner B; Ewers M; Schmidt R; de Leeuw FE; Biessels GJ; Dichgans M; Duering M
    Ann Neurol; 2016 Oct; 80(4):581-92. PubMed ID: 27518166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep microbleeds and periventricular white matter disintegrity are independent predictors of attention/executive dysfunction in non-dementia patients with small vessel disease.
    Cao WW; Wang Y; Dong Q; Chen X; Li YS; Zhou Y; Gao L; Deng Y; Xu Q
    Int Psychogeriatr; 2017 May; 29(5):793-803. PubMed ID: 27938433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Blood Pressure Lowering Intensity With White Matter Network Integrity in Patients With Cerebral Small Vessel Disease.
    Pflanz CP; Egle MS; O'Brien JT; Morris RG; Barrick TR; Blamire AM; Ford GA; Tozer D; Markus HS;
    Neurology; 2022 Oct; 99(17):e1945-e1953. PubMed ID: 35977831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texture Analysis of T1-Weighted and Fluid-Attenuated Inversion Recovery Images Detects Abnormalities That Correlate With Cognitive Decline in Small Vessel Disease.
    Tozer DJ; Zeestraten E; Lawrence AJ; Barrick TR; Markus HS
    Stroke; 2018 Jul; 49(7):1656-1661. PubMed ID: 29866751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.